Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 1998, p. 708-715, Vol. 36, No. 3
Fungus Testing Laboratory,
Received 21 August 1997/Returned for modification 24 October
1997/Accepted 25 November 1997
We report a case of cerebral phaeohyphomycosis in a 36-year-old
male caused by the neurotropic fungus Ramichloridium
obovoideum (Matushima) de Hoog 1977 (Ramichloridium
mackenziei Campbell et Al-Hedaithy 1993). This man resided in the
Middle East, where the fungus appears to be endemic and, possibly,
geographically restricted, since all previous reports of brain
abscesses due to this organism have been for patients indigenous to
this area. As a servant of the Saudi Arabian royal family, he appeared
in the United States seeking treatment for chronic weight loss,
fatigue, decreased memory, and a more recent 2-week history of
right-hand weakness which worsened to involve the entire right upper
extremity. On the day prior to his admission, he had a focal motor
seizure with rotation of the head and eyes to the right, followed by
secondary generalization. A computerized tomogram showed a
ring-enhancing hypodense lesion in the left parietal subcortical region
with associated edema and mass effect. Diagnosis of a fungal etiology was made following a parietal craniotomy and excisional biopsy by
observation of septate, dematiaceous hyphal elements 2 to 3 µm in
width on hematoxylin-and-eosin-stained sections from within areas of
inflammation and necrosis. Culture of the excised material grew out a
dematiaceous mould which was subsequently identified as R. obovoideum. At two months postsurgery and with a regimen of 200 mg of itraconazole twice a day, the patient was doing well and returned
to Saudi Arabia. His condition subsequently deteriorated, however, and
following a 7-month course of itraconzole, he expired. We use this case
to alert clinicians and personnel in clinical mycology laboratories of
the pathogenicity of this organism and its potential occurrence in
patients with central nervous system signs and symptoms who have
resided in the Middle East and to review and/or compare R. obovoideum with other neurotropic, dematiaceous taxa and similar
nonneurotropic, dematiaceous species.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
U.S. Case Report of Cerebral Phaeohyphomycosis
Caused by Ramichloridium obovoideum (R. mackenziei):
Criteria for Identification, Therapy, and Review of Other
Known Dematiaceous Neurotropic Taxa
*
Corresponding author. Mailing address: Fungus Testing
Laboratory, Department of Pathology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78284-7750. Phone: (210) 567-4131. Fax: (210) 567-4076. E-mail:
suttond{at}uthscsa.edu.
Journal of Clinical Microbiology, March 1998, p. 708-715, Vol. 36, No. 3
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»